Resources Contact Us Home
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

Image Number 17 for United States Patent #8129185.

Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4.sup.+CD25.sup.+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

  Recently Added Patents
Battery terminal with current sensor
Determination of copy number variations using binomial probability calculations
Digital broadcasting system and method of processing data in digital broadcasting system
Liquid crystal display
Embedded package and method for manufacturing the same
Push to release cover for a portable electronic device
Electric rotating machine for vehicle
  Randomly Featured Patents
Scroll compressor and baffle for same
Optical scanner
Associative memory device and network frame switch
Projection lenses for display elements and projection systems comprising same
Head slider and disk drive
Plants and seeds of corn variety CV108997
Narrow band radiation filter films
PDA carrying device
Contact lens case